DYNAMIC ANALYSIS OF A DRUG TRANSMISSION MODEL WITH ANTI-DRUG EDUCATION AND MEDIA COVERAGE

被引:1
|
作者
Wang, Xinxin [1 ]
Wang, Xiaoyun [1 ]
Zhang, Fengqin [2 ]
机构
[1] Taiyuan Univ Technol, Coll Math, Taiyuan 030024, Shanxi, Peoples R China
[2] Yuncheng Univ, Sch Math & Informat Technol, Yuncheng 044000, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
Drug transmission model; basic regeneration number; sensitivity; numerical simulation; HEROIN EPIDEMIC; ABUSE; REHABILITATION; ADDICTS;
D O I
10.11948/20220430
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
This paper is devoted to studying the dynamic behavior of drug transmission and the optimal strategy for controlling drug transmission. We constructed a six-dimensional drug transmission model with media coverage, family and public education, dividing the total population into six categories: high-risk susceptible individuals (S), low-risk susceptible individuals with protection awareness (P), psychological addicts (I-PC), physiological addicts (I-PS), drug addicts in community treatment (R-C), drug addicts in compulsory detoxification treatment (R-I). We first calculated the basic regeneration number and analyzed the existence and stability of the equilibrium point of the model. Then, sensitivity analysis and numerical simulations of the parameters are performed. Finally, we gained new insights that when R-0 < 1, controlling the contact between susceptible individuals and drug addicts is more effective than treatment; when R-0 > 1, anti-drug education and media coverage play a greater role, at which point prevention and treatment go hand in hand to control the drug epidemic in a more cost-effective and rapid manner.
引用
收藏
页码:2184 / 2202
页数:19
相关论文
共 50 条
  • [31] Anti-drug social advertising in the modern media space: persuasiveness and cognitive basis
    Brusenskaya, L. A.
    Kulikova, E. G.
    Zolochevskaya, E. Y.
    MEDIAOBRAZOVANIE-MEDIA EDUCATION, 2018, (02): : 71 - 78
  • [32] Response to DeJong and Wallack's article: A critical perspective on the drug Czar's anti-drug media campaign
    McCaffrey, BR
    JOURNAL OF HEALTH COMMUNICATION, 2000, 5 (01) : 73 - 76
  • [33] Strategies to estimate and improve drug tolerance in anti-drug antibody assays
    Buetikofer, Lukas
    Lemaillet, Guy
    Faust, Heinrich
    BIOANALYSIS, 2012, 4 (16) : 1999 - 2012
  • [34] Understanding the Supersensitive Anti-Drug Antibody Assay: Unexpected High Anti-Drug Antibody Incidence and Its Clinical Relevance
    Song, Sam
    Yang, Lili
    Trepicchio, William L.
    Wyant, Timothy
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [35] Antibody drug quantitation in coexistence with anti-drug antibodies on nSMOL bioanalysis
    Iwamoto, Noriko
    Hamada, Akinobu
    Shimada, Takashi
    ANALYTICAL BIOCHEMISTRY, 2018, 540 : 30 - 37
  • [36] Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure
    Kosmac, Miha
    Toplak, Natasa
    Simonini, Gabriele
    Pagnini, Ilaria
    Cimaz, Rolando
    Serbec, Vladka Curin
    Avcin, Tadej
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1099 - S1100
  • [37] THE EFFECT OF CERTOLIZUMAB DRUG CONCENTRATION AND ANTI-DRUG ANTIBODIES ON TNF NEUTRALISATION
    Berkhout, L. C.
    Vogelzang, E. H.
    Hart, M. H.
    Derksen, N. I.
    Wieringa, R.
    van Leeuwen, W. A.
    Krieckaert, C. L.
    de Vries, A.
    Nurmohamed, M. T.
    Wolbink, G.
    Rispens, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 322 - 322
  • [38] The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation
    Berkhout, L. C.
    Vogelzang, E. H.
    Hart, M. H.
    Loeff, F. C.
    Dijk, L.
    Derksen, N. I. L.
    Wieringa, R.
    van Leeuwen, W. A.
    Krieckaert, C. L. M.
    de Vries, A.
    Nurmohamed, M. T.
    Wolbink, G. J.
    Rispens, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 306 - 313
  • [39] Media coverage of drug approvals
    Klotz, RJ
    Ceccoli, SJ
    SOCIAL SCIENCE JOURNAL, 2005, 42 (01): : 129 - 134
  • [40] Sensitivity and Drug Tolerance of Anti-Drug Antibody Screening Assays for Ixekizumab
    Muram, T.
    Nickoloff, B.
    Blauvelt, A.
    Papp, K.
    Gordon, K.
    Stoykov, I.
    Vincent, M.
    Konrad, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S35 - S35